Form 4: TransDigm Group CEO Kevin Stein Executes Stock Option and Sells Shares
SEC Form 4
TransDigm Group's CEO, Kevin Stein, exercised stock options and sold shares held indirectly through the Fortuna Trust on August 12, 2024.
Summary
- On August 12, 2024, Kevin M Stein, President & CEO of TransDigm Group INC, exercised stock options to acquire 10,000 shares of common stock at a price of $270.88 per share.
- Simultaneously, Mr. Stein, through the Fortuna Trust dated June 1, 2018, disposed of 3,186 shares at a weighted average price of $1,226.7416, 4,491 shares at a weighted average price of $1,227.7004, 632 shares at a weighted average price of $1,228.6541, 458 shares at a weighted average price of $1,229.682, 324 shares at a weighted average price of $1,230.5434, 250 shares at a weighted average price of $1,231.8333, 296 shares at a weighted average price of $1,233.2414, 50 shares at a weighted average price of $1,234.856, 129 shares at a weighted average price of $1,236.4636, 181 shares at a weighted average price of $1,237.6402 and 3 shares at a weighted average price of $1,240.03.
- Following these transactions, the number of shares held indirectly by the Fortuna Trust is 8,158.
- Mr. Stein also indirectly holds 163,500 derivative securities (stock options) through the Fortuna Trust.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing insider transactions, with no inherent positive or negative sentiment. It simply reports facts.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions and provides transparency to the market regarding the actions of company executives.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, ensuring compliance with SEC regulations.
- Similar filings are made by executives at companies like Heico and Curtiss-Wright, which also operate in the aerospace and defense sectors.
Stakeholder Impact
- The transactions may have a minor impact on shareholders, potentially influencing short-term stock price fluctuations.
- The filing provides transparency to stakeholders regarding executive compensation and stock ownership.
Key Dates
| Date | Description |
|---|---|
| June 1, 2018 | Date of the Fortuna Trust |
| September 30, 2018 | Date exercisable for stock options |
| August 1, 2022 | Date from which the exercise price has been adjusted for dividends. |
| August 12, 2024 | Date of the stock option exercise and share sales. |
| August 14, 2024 | Date of signature on the Form 4 filing. |
| April 25, 2028 | Expiration date for stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.